Qiming Venture Partners Portfolio Companies Make Ifenxi China AI Large Model Vendors Top 50 List
The ranking focuses on large model vendors' commercialization capabilities, using winning bids as the core evaluation metric to identify vendors with extensive project implementation experience, providing a reference for enterprise users.
Recently, Ifenxi released its inaugural list of China's Top 50 AI Large Model Vendors. The ranking focuses on commercialization capabilities, using won bids as the core evaluation metric to identify large model vendors with substantial project implementation experience, providing a reference for enterprise users.
Portfolio companies of Qiming Venture Partners — Zhipu AI, StepFun, Unisound (09678.HK), Huimei Technology, and UBTECH (09880.HK) — were named to the list.
Zhipu AI, StepFun
(Model)
Unisound, Huimei Technology, UBTECH
(Application)
Named to
China's Top 50 AI Large Model Vendors
· China's Top 50 AI Large Model Vendors
To qualify, companies must offer AI large model products and services, including computing infrastructure, large models and toolchains, and AI applications, primarily serving industries such as finance, energy, manufacturing, automotive, and retail. The evaluation period covers January 1, 2024 to December 31, 2024. Ifenxi ranked companies based on the number of AI large model-related products and services they won bids for in 2024.
Source | Ifenxi
Past Coverage
Qiming Stars | 3 Qiming Venture Partners Portfolio Companies Named to 2025 Ifenxi AIGC Vendor Panorama Report Qiming Stars | Over 10 Qiming Venture Partners Portfolio Companies Named to 2025 AI Cloud 100 China Speaker Lineup Revealed | Register Now for 2025 WAIC Qiming Venture Partners · Entrepreneurship and Investment Forum — Venture Capital Enters a Resonance Cycle of AI Technology and Applications
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), GenScript ProBio (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.